Placenta Accreta, Increta, And Percreta

Obstetrics and Gynecology Clinics of North America

Volumn 40, Issue 1, 2013, Pages 137-154

  Wortman, Alison C ^a   Alexander, James M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Abnormal; Accreta; Hemorrhage; Increta; Percreta; Placenta; Placentation; Pregnancy

Indexed keywords

METHOTREXATE;

ALTERNATIVE MEDICINE; ANEMIA; CESAREAN SECTION; DIAGNOSTIC IMAGING; DIARRHEA; DIGESTIVE SYSTEM ULCER; DISEASE CLASSIFICATION; DRUG FATALITY; DRUG HYPERSENSITIVITY; GRAY SCALE ECHOGRAPHY; HUMAN; HYSTERECTOMY; INTERVENTIONAL RADIOLOGY; LEUKOPENIA; LIVER TOXICITY; MANAGED CARE; MOUTH ULCER; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTETRIC ANESTHESIA; OBSTETRIC HEMORRHAGE; PLACENTA ACCRETA; PLACENTA DISORDER; PLACENTA INCRETA; PLACENTAL DELIVERY; POSTOPERATIVE CARE; POSTPARTUM HEMORRHAGE; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RESUSCITATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPTIC SHOCK; SURGICAL TECHNIQUE; VOMITING;

ANESTHESIA; CESAREAN SECTION; DILATATION AND CURETTAGE; FEMALE; HUMANS; HYSTERECTOMY; MATERNAL AGE; NORTH AMERICA; PATIENT SELECTION; PLACENTA ACCRETA; PLACENTA PREVIA; POSTPARTUM HEMORRHAGE; PREGNANCY; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 84875238317     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2012.12.002     Document Type: Review

References (81)

1. Irving F., Hertig A. A study of placenta accreta. Surg Gynecol Obstet 1937, 64:178-200.
2. Breen J.L., Neubecker R., Gregori C.A., et al. Placenta accreta, increta, and percreta. A survey of 40 cases. Obstet Gynecol 1977, 49(1):43-47.
3. Read J.A., Cotton D.B., Miller F.C. Placenta accreta: changing clinical aspects and outcome. Obstet Gynecol 1980, 56(1):31-34.
4. Miller D.A., Chollet J.A., Goodwin T.M. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997, 177(1):210-214.
5. Wu S., Kocherginsky M., Hibbard J.U. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005, 192(5):1458-1461.
6. MacDorman M.F., Menacker F., Declercq E. Cesarean birth in the United States: epidemiology, trends, and outcomes. Clin Perinatol 2008, 35(2):293-307. v.
7. Hamilton B.E., Martin J.A., Ventura S.J. Births: preliminary data for 2010. Natl Vital Stat Rep 2011, 60(2):1-26.
8. Cunningham F.G., Williams J.W. Obstetrical hemorrhage. William's obstetrics 2010, 776-780. McGraw-Hill, Medical, New York. 23rd edition. F.G. Cunningham, K.J. Leveno, S.L. Bloom (Eds.).
9. Silver R.M., Landon M.B., Rouse D.J., et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006, 107(6):1226-1232.
10. Al-Serehi A., Mhoyan A., Brown M., et al. Placenta accreta: an association with fibroids and Asherman syndrome. J Ultrasound Med 2008, 27(11):1623-1628.
11. Sharp H.T. Endometrial ablation: postoperative complications. Am J Obstet Gynecol 2012, 207(4):242-247.
12. Pron G., Mocarski E., Bennett J., et al. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol 2005, 105(1):67-76.
13. Lim P.S., Greenberg M., Edelson M.I., et al. Utility of ultrasound and MRI in prenatal diagnosis of placenta accreta: a pilot study. AJR Am J Roentgenol 2011, 197(6):1506-1513.
14. Chou M.M., Ho E.S., Lee Y.H. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol 2000, 15(1):28-35.
15. Comstock C.H., Love J.J., Bronsteen R.A., et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004, 190(4):1135-1140.
16. Warshak C.R., Eskander R., Hull A.D., et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 2006, 108(3 Pt 1):573-581.
17. Shih J.C., Palacios Jaraquemada J.M., Su Y.N., et al. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol 2009, 33(2):193-203.
18. Twickler D.M., Lucas M.J., Balis A.B., et al. Color flow mapping for myometrial invasion in women with a prior cesarean delivery. J Matern Fetal Med 2000, 9(6):330-335.
19. Wong H.S., Cheung Y.K., Williams E. Antenatal ultrasound assessment of placental/myometrial involvement in morbidly adherent placenta. Aust N Z J Obstet Gynaecol 2012, 52(1):67-72.
20. Lax A., Prince M.R., Mennitt K.W., et al. The value of specific MRI features in the evaluation of suspected placental invasion. Magn Reson Imaging 2007, 25(1):87-93.
21. Palacios Jaraquemada J.M., Bruno C.H. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand 2005, 84(8):716-724.
22. Briggs G.G., Freeman R.K., Yaffe S.J. Gadopentetate dimeglumine. Drugs in pregnancy and lactation: reference guide to fetal and neonatal risk 2008, 804-805. Lippincott Williams & Wilkins, Philadelphia. 8th edition. G.G. Briggs, R.K. Freeman, S.J. Yaffe (Eds.).
23. Wack C., Steger-Hartmann T., Mylecraine L., et al. Toxicological safety evaluation of gadobutrol. Invest Radiol 2012, 47(11):611-623.
24. Webb J.A., Thomsen H.S., Morcos S.K., et al. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005, 15(6):1234-1240.
25. Yang L., Krefting I., Gorovets A., et al. Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the food and drug administration. Radiology 2012, 265(1):248-253.
26. Kanal E., Barkovich A.J., Bell C., et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol 2007, 188(6):1447-1474.
27. Eller A.G., Bennett M.A., Sharshiner M., et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 2011, 117(2 Pt 1):331-337.
28. Pacheco L.D., Gei A.F. Controversies in the management of placenta accreta. Obstet Gynecol Clin North Am 2011, 38(2):313-322. xi.
29. Imdad A., Bhutta Z.A. Routine iron/folate supplementation during pregnancy: effect on maternal anaemia and birth outcomes. Paediatr Perinat Epidemiol 2012, 26(Suppl 1):168-177.
30. Krafft A., Bencaiova G., Breymann C. Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone. Fetal Diagn Ther 2009, 25(2):239-245.
31. Harris S.A., Payne G., Putman J.M. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy. Obstet Gynecol 1996, 87(5 Pt 2):812-814.
32. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Canadian Orthopedic Perioperative Erythropoietin Study Group. Lancet 1993, 341(8855):1227-1232.
33. Cazzola M., Mercuriali F., Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997, 89(12):4248-4267.
34. Hudon L., Belfort M.A., Broome D.R. Diagnosis and management of placenta percreta: a review. Obstet Gynecol Surv 1998, 53(8):509-517.
35. Briggs G.G., Freeman R.K., Yaffe S.J. Epoetin alfa. Drugs in pregnancy and lactation: reference guide to fetal and neonatal risk 2008, 640-643. Lippincott Williams & Wilkins, Philadelphia. 8th edition. G.G. Briggs, R.K. Freeman, S.J. Yaffe (Eds.).
36. Committee opinion no. 529: placenta accreta. Obstet Gynecol 2012, 120(1):207-211.
37. Chestnut D.H., Dewan D.M., Redick L.F., et al. Anesthetic management for obstetric hysterectomy: a multi-institutional study. Anesthesiology 1989, 70(4):607-610.
38. Stafford I.A., Dashe J.S., Shivvers S.A., et al. Ultrasonographic cervical length and risk of hemorrhage in pregnancies with placenta previa. Obstet Gynecol 2010, 116(3):595-600.
39. Robinson B.K., Grobman W.A. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol 2010, 116(4):835-842.
40. Spong C.Y., Mercer B.M., D'Alton M., et al. Timing of indicated late-preterm and early-term birth. Obstet Gynecol 2011, 118(2 Pt 1):323-333.
41. Jolley J.A., Nageotte M.P., Wing D.A., et al. Management of placenta accreta: a survey of Maternal-Fetal Medicine practitioners. J Matern Fetal Neonatal Med 2012, 25(6):756-760.
42. Lilker S.J., Meyer R.A., Downey K.N., et al. Anesthetic considerations for placenta accreta. Int J Obstet Anesth 2011, 20(4):288-292.
43. Kuczkowski K.M. A review of current anesthetic concerns and concepts for cesarean hysterectomy. Curr Opin Obstet Gynecol 2011, 23(6):401-407.
44. Kruskall M.S., Leonard S., Klapholz H. Autologous blood donation during pregnancy: analysis of safety and blood use. Obstet Gynecol 1987, 70(6):938-941.
45. Catling S. Blood conservation techniques in obstetrics: a UK perspective. Int J Obstet Anesth 2007, 16(3):241-249.
46. Fong J., Gurewitsch E.D., Kump L., et al. Clearance of fetal products and subsequent immunoreactivity of blood salvaged at cesarean delivery. Obstet Gynecol 1999, 93(6):968-972.
47. Pacheco L.D., Saade G.R., Gei A.F., et al. Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol 2011, 205(6):526-532.
48. Cohen M.J. Towards hemostatic resuscitation: the changing understanding of acute traumatic biology, massive bleeding, and damage-control resuscitation. Surg Clin North Am 2012, 92(4):877-891. viii.
49. Alexander J.M., Sarode R., McIntire D.D., et al. Whole blood in the management of hypovolemia due to obstetric hemorrhage. Obstet Gynecol 2009, 113(6):1320-1326.
50. Tan C.H., Tay K.H., Sheah K., et al. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. AJR Am J Roentgenol 2007, 189(5):1158-1163.
51. Bodner L.J., Nosher J.L., Gribbin C., et al. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol 2006, 29(3):354-361.
52. Levine A.B., Kuhlman K., Bonn J. Placenta accreta: comparison of cases managed with and without pelvic artery balloon catheters. J Matern Fetal Med 1999, 8(4):173-176.
53. Bishop S., Butler K., Monaghan S., et al. Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta. Int J Obstet Anesth 2011, 20(1):70-73.
54. Panici P.B., Anceschi M., Borgia M.L., et al. Intraoperative aorta balloon occlusion: fertility preservation in patients with placenta previa accreta/increta. J Matern Fetal Neonatal Med 2012, 25(12):2512-2516.
55. Sovik E., Stokkeland P., Storm B.S., et al. The use of aortic occlusion balloon catheter without fluoroscopy for life-threatening post-partum haemorrhage. Acta Anaesthesiol Scand 2012, 56(3):388-393.
56. Belfort M.A. Placenta accreta. Am J Obstet Gynecol 2010, 203(5):430-439.
57. Gilstrap L.C., Cunningham F.G., VanDorsten J.P. Anatomy, incisions, and closures. Operative obstetrics 2002, 51-52. McGraw-Hill, Medical Publisher Division, New York. 2nd edition. L.C. Gilstrap, F.G. Cunningham, J.P. VanDorsten (Eds.).
58. Gilstrap L.C., Cunningham F.G., VanDorsten J.P. Obstetric hysterectomy. Operative obstetrics 2002, 279-286. McGraw-Hill, Medical Publisher Division, New York. 2nd edition. L.C. Gilstrap, F.G. Cunningham, J.P. VanDorsten (Eds.).
59. Plauche W.C., Gruich F.G., Bourgeois M.O. Hysterectomy at the time of cesarean section: analysis of 108 cases. Obstet Gynecol 1981, 58(4):459-464.
60. Matsubara S., Ohkuchi A., Yashi M., et al. Opening the bladder for cesarean hysterectomy for placenta previa percreta with bladder invasion. J Obstet Gynaecol Res 2009, 35(2):359-363.
61. Pelosi M.A., Pelosi M.A. Modified cesarean hysterectomy for placenta previa percreta with bladder invasion: retrovesical lower uterine segment bypass. Obstet Gynecol 1999, 93(5 Pt 2):830-833.
62. Rossi A.C., Lee R.H., Chmait R.H. Emergency postpartum hysterectomy for uncontrolled postpartum bleeding: a systematic review. Obstet Gynecol 2010, 115(3):637-644.
63. Vrachnis N., Iavazzo C., Salakos N., et al. Uterine tamponade balloon for the management of massive hemorrhage during cesarean section due to placenta previa/increta. Clin Exp Obstet Gynecol 2012, 39(2):255-257.
64. Cho J.H., Jun H.S., Lee C.N. Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstet Gynecol 2000, 96(1):129-131.
65. Dildy G.A., Scott J.R., Saffer C.S., et al. An effective pressure pack for severe pelvic hemorrhage. Obstet Gynecol 2006, 108(5):1222-1226.
66. Eller A.G., Porter T.F., Soisson P., et al. Optimal management strategies for placenta accreta. BJOG 2009, 116(5):648-654.
67. Unal O., Kars B., Buyukbayrak E.E., et al. The effectiveness of bilateral hypogastric artery ligation for obstetric hemorrhage in three different underlying conditions and its impact on future fertility. J Matern Fetal Neonatal Med 2011, 24(10):1273-1276.
68. Porreco R.P., Stettler R.W. Surgical remedies for postpartum hemorrhage. Clin Obstet Gynecol 2010, 53(1):182-195.
69. Keogh J., Tsokos N. Aortic compression in massive postpartum haemorrhage-an old but lifesaving technique. Aust N Z J Obstet Gynaecol 1997, 37(2):237-238.
70. Soltan M.H., Sadek R.R. Experience managing postpartum hemorrhage at Minia University Maternity Hospital, Egypt: no mortality using external aortic compression. J Obstet Gynaecol Res 2011, 37(11):1557-1563.
71. Bretelle F., Courbiere B., Mazouni C., et al. Management of placenta accreta: morbidity and outcome. Eur J Obstet Gynecol Reprod Biol 2007, 133(1):34-39.
72. Sentilhes L., Ambroselli C., Kayem G., et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010, 115(3):526-534.
73. Sentilhes L., Kayem G., Ambroselli C., et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod 2010, 25(11):2803-2810.
74. Mussalli G.M., Shah J., Berck D.J., et al. Placenta accreta and methotrexate therapy: three case reports. J Perinatol 2000, 20(5):331-334.
75. Butt K., Gagnon A., Delisle M.F. Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta. Obstet Gynecol 2002, 99(6):981-982.
76. Lee P.S., Bakelaar R., Fitpatrick C.B., et al. Medical and surgical treatment of placenta percreta to optimize bladder preservation. Obstet Gynecol 2008, 112(2 Pt 2):421-424.
77. Morken N.H., Kahn J.A. Placenta accreta and methotrexate treatment. Acta Obstet Gynecol Scand 2006, 85(2):248-250.
78. Furst D.E., Ulrich R.W., Prakash S. Chapter 36. Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics, drugs used in Gout. Basic & clinical pharmacology 2012, McGraw-Hill, New York, Available at:, Accessed November 7, 2012. http://www.accessmedicine.com.foyer.swmed.edu/content.aspx%3FaID=55827134, 12th edition. B.G. Katzung, S.B. Masters, A.J. Trevor (Eds.).
79. American College of Obstetricians, Gynecologists ACOG Practice Bulletin No. 100: critical care in pregnancy. Obstet Gynecol 2009, 113(2 Pt 1):443-450.
80. Tam Tam K.B., Dozier J., Martin J.N. Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review. J Matern Fetal Neonatal Med 2012, 25(4):329-334.
81. Committee on Practice Bulletins-Gynecology ACoO, Gynecologists ACOG Practice Bulletin No. 84: prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 2007, 110(2 Pt 1):429-440.